Impact of frailty on antihypertensive treatment in older adults

1 September 2025 (13:45 - 13:55)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Katie Harris

The George Institute for Global Health, Sydney (Australia)

4 More presentations in this session

Presentation thumbnail

Clinical outcomes and prognostic implications in super-elderly out-of-hospital cardiac arrest - a multicenter analysis

Associate Professor Y. Lee (Incheon, KR)

Abstract Slides

Presentation thumbnail

Intervention versus conservative treatment for very elderly patients with NSTEMI and frailty: a multi-center observational study

Miss C. Liu (Tianjin, CN)

Abstract Slides

Presentation thumbnail

Age-stratified analysis of real-world lipid-lowering therapy use and LDL-C goal attainment at 1-year follow-up: insights from the European SANTORINI study

Professor D. Connolly (Birmingham, GB)

Abstract Slides

Presentation thumbnail

Low-dose edoxaban in patients 80 years and older with atrial fibrillation and dose-reduction criteria: randomized analysis between edoxaban 15 mg and 30 mg

Doctor A. Zimerman (Porto Alegre, BR)

Abstract Slides

Access the full session

Session thumbnail

Management of cardiovascular disease in older adults

The Event

Event poster

ESC Congress 2025

1 September 2025 13:45 CET

You may be interested in

Congress Presentation

Impact of frailty on the effectiveness of intervention to reduce adverse outcomes in heart failure

Congress Presentation

Efficacy and safety of finerenone according to frailty in patients with heart failure: a prespecified analysis of the FINEARTS-HF trial

Congress Presentation

The impact of frailty syndrome on the occurrence of anxiety disorders and depression in patients with arterial hypertension

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources